Comparisons of hallucinogenic phenylisopropylamine binding affinities at cloned human 5-HT(2A), 5-HT(2B) and 5-HT(2C) receptors

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 359, Issue 1, 1999, Pages 1-6

  Nelson, D L ^a   Lucaites, V L ^a   Wainscott, D B ^a   Glennon, R A ^b  

^a ELI LILLY AND COMPANY   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

5 HT2 receptor subpopulations; Hallucinogenic agents; Serotonin receptors

Indexed keywords

AMPHETAMINE; PSYCHEDELIC AGENT; RECEPTOR SUBTYPE; SEROTONIN 2A RECEPTOR; SEROTONIN 2B RECEPTOR; SEROTONIN 2C RECEPTOR;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CONFORMATIONAL TRANSITION; DRUG ANTAGONISM; DRUG RECEPTOR BINDING; HUMAN; HUMAN CELL; MOLECULAR CLONING; NONHUMAN; RECEPTOR AFFINITY; RECEPTOR INTRINSIC ACTIVITY; RECEPTOR OCCUPANCY; RECEPTOR SENSITIVITY; SEROTONINERGIC SYSTEM; STRUCTURE ACTIVITY RELATION;

EID: 0033063606     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00005315     Document Type: Article

References (28)

1. 2C receptors in mediating the discriminative stimulus properties of m-chlorophenylpiperazine (mCPP). Eur J Pharmacol 257:27-38
2. 50) of an enzymatic reaction. Biochem Pharmacol 22:3099-3108
3. 1D receptors. FEBS Lett 352:393-399
4. Cohen ML, Fuller RW (1983) Antagonism of vascular serotonin receptors by m-chlorophenylpiperazine and m-trifluoromethylphenylpiperazine. Life Sci 32:711-718
5. 2C receptors in the stimulus effects of hallucinogenic drugs. Psychopharmacology 121:347-356
6. Foguet M, Hoyer D, Pardo LA, Parekh A, Kluxen FW, Kalkman HO, Stuhmer W, Lubbert H (1992) Cloning and functional characterization of the rat stomach fundus serotonin receptor. EMBO J 11:3481-3487
7. Germine M, Goddard AW, Sholomskas DE, Woods SW, Charney DS, Heninger GR (1994) Response to meta-chlorophenylpiperazine in panic disorder patients and healthy subjects: influence of reduction in intravenous dosage. Psychiatr Res Nov 54:15-133
8. Glennon RA (1985) The role of serotonin in the mechanism of action of hallucinogenic agents. In: Green AR (ed) Neuropharmacology of serotonin. Oxford University Press, London
9. Glennon RA (1992) Animal models for assessing hallucinogenic agents. In: Boulton A, Wu P (eds) Animal models for assessing drugs of abuse. Humana Press, Clifton, pp 345-381
10. Glennon RA (1996) Classical hallucinogens. In: Schuster CR, Kuhar MJ (eds) Pharmacological aspects of drug dependence. Springer, Berlin Heidelberg New York, pp 343-371
11. 2 serotonin receptors: evidence for a lack of selectivity. J Med Chem 35:734-740
12. Hoyer D, Clarke DE, Fozard JR, Hartig PR, Martin GR, Mylecharane EJ, Saxena PR, Humphrey PPA (1994) International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol Rev 46:157-203
13. Ishida M, Otani K, Kaneko S, Ohkubo T, Osanai T, Yasui N, Mihara K, Higuchi H, Sugawara K (1995) Effects of various factors on steady state plasma concentrations of trazodone and its active metabolite m-chlorophenylpiperazine. Int Clin Psychopharmacol Sep 10:143-146
14. 1C-selective antagonist. J Med Chem 36:2519-2525
15. 2C serotonin receptors. Med Chem Res 6:197-211
16. Jacob P III, Shulgin AT (1994) Structure-activity relationships of the classic hallucinogens and their analogs. In: Lin GC, Glennon RA (eds) Hallucinogens: an update. US Department of Health and Human Services, Washington, DC. pp 74-91
17. Johnson MP, Loncharich RJ, Baez M, Nelson DL (1994) Species variations in transmembrane region V of the 5-hydroxytryptamine Type 2A receptor alter the structure-activity relationship of certain ergolines and tryptamines. Mol Pharmacol 45:277-286
18. 2F) from rat stomach fundus. Mol Pharmacol 42:549-557
19. 2B receptor. Mol Pharmacol 46:227-234
20. 2-like receptor. Expression in brain, heart and intestine. FEBS Lett 312:203-207
21. 2) subfamily of receptors: pharmacological challenges. Med Chem Res 3:306-316
22. 2B serotonin receptor. FEBS Lett 342:85-90
23. Schreiber R, Brocco M, Millan MJ (1994) Blockade of the discriminative stimulus effects of DOI by MDL 100,907 and the atypical antipsychotics cozapine and risperidone. Eur J Pharmacol 264:99-102
24. 2 serotonin receptors. J Med Chem 33:1032-1036
25. Swillens S (1992) How to estimate the total receptor concentration when the specific radioactivity of the ligand is unknown. Trends Pharmacol Sci 13:430-434
26. 2F receptor. Mol Pharmacol 43:419-426
27. 2B receptor: evidence for species differences. J Pharmacol Exp Ther 276:720-727
28. Westkaemper R (1993) Serotonin receptors: molecular genetics and molecular modeling. Med Chem Res 3:269-272